Date published: 2026-4-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Mizoribine Hydrobromide (CAS 50924-49-7 (non-salt))

0.0(0)
Write a reviewAsk a question

Application:
Mizoribine Hydrobromide is an immunosuppressant agent
CAS Number:
50924-49-7 (non-salt)
Molecular Weight:
259.22
Molecular Formula:
C9H13BrN3O6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Mizoribine Hydrobromide, cataloged under CAS number 50924-49-7, is the hydrobromide salt form of mizoribine, a nucleoside inhibitor of inosine monophosphate dehydrogenase (IMPDH). This enzyme plays a crucial role in the de novo pathway of guanine nucleotide synthesis, which is essential for DNA and RNA synthesis in cells. Mizoribine Hydrobromide acts by competitively inhibiting IMPDH, leading to a reduction in guanine nucleotide pools, particularly guanosine triphosphate (GTP), which is vital for RNA and DNA synthesis. This action results in the suppression of cell proliferation, particularly in rapidly dividing cells. In research, Mizoribine Hydrobromide is used extensively to study cellular proliferation processes and the biochemical pathways involved in nucleotide biosynthesis. It serves as a tool for investigating the effects of guanine nucleotide depletion on various cellular functions, including DNA replication, RNA transcription, and protein synthesis. Furthermore, it helps in elucidating the cellular responses to nucleotide imbalance, such as activation of stress response pathways and cell cycle arrest. Research involving this compound contributes significantly to the understanding of molecular biology and biochemistry of cell growth and division, providing insights into the fundamental mechanisms that control cellular processes.


Mizoribine Hydrobromide (CAS 50924-49-7 (non-salt)) References

  1. Mizoribine corrects defective nephrin biogenesis by restoring intracellular energy balance.  |  Nakajo, A., et al. 2007. J Am Soc Nephrol. 18: 2554-64. PMID: 17687078
  2. The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.  |  Takeuchi, S., et al. 2010. Nephron Exp Nephrol. 116: e3-10. PMID: 20502051
  3. Modelling the effects of inhibitors of guanine nucleotide synthesis: implications for studies of cellular differentiation pathways.  |  Thomas, GM. 2010. Biochem Soc Trans. 38: 1314-8. PMID: 20863305
  4. Inhibition of expression of cyclin A in human B cells by an immunosuppressant mizoribine.  |  Hirohata, S. and Yanagida, T. 1995. J Immunol. 155: 5175-83. PMID: 7594527
  5. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis.  |  Catapano, CV., et al. 1995. Mol Pharmacol. 47: 948-55. PMID: 7746281
  6. Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice.  |  Shimizu, M., et al. 1998. Nephron. 79: 67-72. PMID: 9609465

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Mizoribine Hydrobromide, 10 mg

sc-205755
10 mg
$140.00

Mizoribine Hydrobromide, 25 mg

sc-205755A
25 mg
$280.00